首页> Breast cancer research and treatment> Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers.

Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers.

导出 OA

翻译打印收藏纠错

第一作者： Kristen N,Stevens

第一单位： Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

作者： Kristen N,Stevens ^[1] ; Xianshu,Wang ; Zachary,Fredericksen ; Vernon S,Pankratz ; Mark H,Greene ; Irene L,Andrulis ; Mads,Thomassen ; Maria,Caligo ; Swedish Breast Cancer Study, Sweden (SWE-BRCA) ; Katherine L,Nathanson ; Anna,Jakubowska ; Ana,Osorio ; Ute,Hamann ; Andrew K,Godwin ; Dominique,Stoppa-Lyonnet ; Melissa,Southey ; Saundra S,Buys ; Christian F,Singer ; Thomas V O,Hansen ; Adalgeir,Arason ; Kenneth,Offit ; Marion,Piedmonte ; Marco,Montagna ; Evgeny,Imyanitov ; Laima,Tihomirova ; Lara,Sucheston ; Mary,Beattie ; HEreditary Breast and Ovarian Cancer Group Netherlands (HEBON) ; German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC) ; Susan L,Neuhausen ; CONsorzio Studi ITaliani sui Tumori Ereditari Alla Mammella (CONSIT Team) ; Csilla I,Szabo ; kConFab ; Jacques,Simard ; Amanda B,Spurdle ; Sue,Healey ; Xiaoqing,Chen ; Timothy R,Rebbeck ; Douglas F,Easton ; Georgia,Chenevix-Trench ; Antonis C,Antoniou ; Fergus J,Couch

作者单位： Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. ^[1]